Enrichment of CES1 Carriers in the Pharmacogenomics Anti-Platelet Intervention Study
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 17 Apr 2018
At a glance
- Drugs Aspirin (Primary) ; Clopidogrel (Primary)
- Indications Acute coronary syndromes; Angina pectoris; Atherosclerosis; Cardiovascular disorders; Coronary thrombosis; Ischaemic heart disorders; Myocardial infarction; Peripheral arterial occlusive disorders; Stroke; Unstable angina pectoris
- Focus Pharmacogenomic; Therapeutic Use
- 10 Apr 2018 Planned initiation date changed from 1 Mar 2018 to 1 Sep 2018.
- 24 Oct 2017 Planned initiation date changed from 1 Sep 2017 to 1 Mar 2018.
- 19 Jun 2017 New trial record